Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 31722-215

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 31722-215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Dapto Structure)

Chemical structure diagram of the active ingredient Daptomycin. The diagram displays the molecular configuration using standard chemical notation, showing atoms and bonds typical for this cyclic lipopeptide antibiotic.*

FDA Label Image

Daptomycin-carton-10s-vial-label (Daptomycin Carton 10s Vial Label)

Packaging label for Daptomycin for Injection 350 mg per vial, a lyophilized powder for solution injection. The label indicates reconstitution with 7 mL of 0.9% sodium chloride to yield a 50 mg/mL concentration, for intravenous use only. The product is manufactured by Camber Pharmaceuticals, Inc. and supplied in a carton containing 10 single-dose vials. The label includes storage instructions to refrigerate and notes that it must be reconstituted before use.*

FDA Label Image

Daptomycin-carton-1s-vial-label (Daptomycin Carton 1s Vial Label)

Flat packaging label for Daptomycin injection, powder, lyophilized, for solution, 350 mg per vial by Camber Pharmaceuticals, Inc. The label details reconstitution with 7 mL 0.9% sodium chloride to yield 50 mg/mL concentration. It states the product must be refrigerated and is for intravenous use only, single-dose vial. Manufacturing details and barcode are also visible.*

FDA Label Image

Daptomycin-vial-label (Daptomycin Vial Label)

Label for Daptomycin for Injection 350 mg per vial, a lyophilized powder for intravenous solution by Camber Pharmaceuticals, Inc. Instructions indicate reconstitution with 7 mL 0.9% sodium chloride to 50 mg/mL concentration. Label states the product is sterile, preservative-free, non-latex, to be refrigerated, single-dose, and for intravenous use only. Manufactured by Aspiro Pharma Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.